A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
Conditions: Melanoma; Head and Neck Squamous Cell Carcinoma; Pancreatic Ductal Adenocarcinoma; Colorectal Cancer; Solid Tumor Interventions: Drug: IPN01194; Drug: IPN01194 Sponsors: Ipsen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

Myeloprotection With Trilaciclib in Pan-cancer Population
Conditions: Non-Small Cell Lung Cancer; Breast Cancer; Endometrial Cancer; Cervical Cancer; Head And Neck Squamous Cell Carcinomas Interventions: Drug: Trilaciclib Injection; Drug: Paclitaxel; Drug: Carboplatin Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials

RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3
Conditions: Head and Neck Cancer; Radiotherapy Side Effect Interventions: Radiation: Dose painting Sponsors: Oslo University Hospital; Haukeland University Hospital; St. Olavs Hospital; Norwegian University of Life Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials

Heavy Strength Training in Head and Neck Cancer Survivors
Conditions: Head and Neck Neoplasms; Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma; Head and Neck Carcinoma Interventions: Other: Experimental Sponsors: University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials

A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors
Conditions: Neoplasms; Non-small-cell Lung Cancer; Melanoma; Squamous Cell Carcinoma of the Head and Neck; Renal Cell Carcinoma; Urothelial Carcinoma; Colorectal Carcinoma; Ovarian Carcinoma Interventions: Drug: PF-07820435; Biological: Sasanlimab Sponsors: Pfizer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials

Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia
Conditions: Oropharynx Cancer; Head and Neck Cancer; Xerostomia Interventions: Radiation: standard radiotherapy; Radiation: experimental radiotherapy Sponsors: UNC Lineberger Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials

Topical Anaesthesia in Cutaneous Head and Neck Surgery
Conditions: Pain, Acute; Head and Neck Cancer; Cutaneous Tumor Interventions: Drug: EMLA; Drug: Ethyl chloride; Drug: Aqueous cream BP Sponsors: University Hospital Waterford Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials

A Phase 0 Multicenter Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
Conditions: Head and Neck Squamous Cell Carcinoma; Soft Tissue Sarcoma Adult; Triple Negative Breast Cancer Interventions: Drug: PBA-0405 Sponsors: Pure Biologics S.A.; Presage Biosciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials

Acupuncture for Prevention and Treatment of Oral-related Complications Caused by Radiotherapy for Head and Neck Cancer
Conditions: Malignant Tumor of Head and/or Neck; Radiotherapy; Complications Interventions: Device: verum acupuncture; Device: sham acupuncture Sponsors: West China Hospital; West China Fourth Hospital, Sichuan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials

Influencing Factors for Physical Activity in People With Head and Neck Cancer
Conditions: Advanced Head and Neck Squamous Cell Carcinoma Sponsors: Kantonsspital Winterthur KSW; Eastern Switzerland University of Applied Sciences; University of Applied Sciences of Western Switzerland; UMC Utrecht; University of Lausanne; Zurich University of Applied Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Conditions: Head and Neck Cancer; Malignant Melanoma; Colorectal Cancer; Renal Cell Carcinoma; Cervical Cancer; Breast Cancer Interventions: Drug: GM103 (Part A); Drug: GM103 (Part B); Drug: GM103 and Pembrolizumab (Part C) Sponsors: GeneMedicine Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Conditions: Advanced Esophageal Squamous Cell Carcinoma; Advanced Renal Cell Carcinoma; Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8; Clinical Stage IIB Cutaneous Melanoma AJCC v8; Clinical Stage IIC Cutaneous Melanoma AJCC v8; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8; Esophageal Carcinoma; Gastroesophageal Junction Adenocarcinoma; Hepatocellular Carcinoma; Locally Advanced Urothelial Carcinoma; Lung Non-Small Cell Carcinoma; Malignan...
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials

Comparing Radiotherapy Immobilization Systems for Anxious HNC Patients
Conditions: Head and Neck Cancer; Claustrophobia; Anxiety Interventions: Device: OSMS position management Sponsors: Centre hospitalier de l ' Universit é de Montréal (CHUM) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials

a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients
Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Radiation: Hyperfractionated radiotherpy; Radiation: Control group Sponsors: Lund University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials

A Study of MGC026 in Participants With Advanced Solid Tumors
Conditions: Advanced Solid Tumor; Advanced Cancer; Metastatic Cancer; Squamous Cell Carcinoma of Head and Neck; Non Small Cell Lung Cancer; Small-cell Lung Cancer; Bladder Cancer; Sarcoma; Endometrial Cancer; Melanoma; Castration Resistant Prostatic Cancer; Cervical Cancer; Colorectal Cancer; Gastric Cancer; Gastro-esophageal Cancer; Pancreas Cancer; Clear Cell Renal Cell Carcinoma; Hepatocellular Carcinoma; Platinum-resistant Ovarian Cancer Interventions: Biological: MGC026 Dose Escalation; Biological: MGC026 Dose for Expansion Sponsors: MacroGenics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials